Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients


Ozdemir N., Aksoy S., Sendur M. A. N. , Akinci M. B. , Yazici O., Budakoglu B., ...Daha Fazla

JOURNAL OF BUON, cilt.18, ss.831-837, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 18 Konu: 4
  • Basım Tarihi: 2013
  • Dergi Adı: JOURNAL OF BUON
  • Sayfa Sayıları: ss.831-837

Özet

Purpose: To evaluate the activity and toxicity of the combination of capecitabine and cisplatin (CapCisp) in anthracycline- and taxane-pretreated HER-2 negative metastatic breast carcinoma (MBC) female patients.